Active Ingredient History
Tenecteplase, sold under the trade names TNKase, Metalyse and Elaxim, is an enzyme used as a thrombolytic drug. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Myocardial Infarction (approved 2000)
Arterial Occlusive Diseases (Phase 2/Phase 3)
Brain Ischemia (Phase 2)
Catheters (Phase 3)
Cerebral Arteries (Phase 2)
Cerebral Infarction (Phase 2)
Cerebrovascular Disorders (Phase 3)
COVID-19 (Phase 4)
Heart Arrest (Phase 3)
Hemodialysis, Home (Phase 3)
Intracranial Thrombosis (Phase 3)
Ischemic Stroke (Phase 3)
Myocardial Infarction (Phase 4)
Nervous System Diseases (Phase 2)
Pleural Effusion (Phase 2/Phase 3)
Pulmonary Embolism (Phase 4)
Respiratory Distress Syndrome (Phase 1)
Respiratory Insufficiency (Phase 2)
Retinal Artery Occlusion (Phase 3)
Severe Acute Respiratory Syndrome (Phase 2)
ST Elevation Myocardial Infarction (Phase 3)
Stroke (Phase 4)
Thrombosis (Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
